Simmons & Simmons advises global life sciences clients on the full range of contentious and non-contentious matters, handling regulatory advice regarding clinical trials, market access, investigations, and interactions with healthcare organisations. The firm is active in cross-border patent litigation, with Scott Parker leading multijurisdictional disputes for pharma and biotech companies, and product liability cases. The team also advises on high-value transactions, with a focus on international licensing and collaboration deals and M&A. Michael Gavey is a specialist in IP-focused transactions and disputes, as well as digital health, while Lydia Torne leads on IP transactions and regulatory compliance issues. Hayley Davis, who arrived in July 2024 from Goodwin, further strengthens the firm’s capacity in digital health and medtech. Kevin Mooney is no longer at the firm.
Legal 500 redaktioneller Kommentar
Anwält*innen
Leading partners
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Next Generation Partners
Juniorpartner*innen, die im Markt von Mandanten und Wettbewerbern anerkannt werden und in einigen Mandaten eine Schlüsselrolle einnehmen.
Weitere Kernanwält*innen
Scott Parker; Michael Gavey; Lydia Torne; Hayley Davis